Grifols (GIKLY) Cash from Financing Activities (2010 - 2020)

Grifols (GIKLY) posted Cash from Financing Activities of -$121.5 million for Q1 2020, up 54.2% quarter-over-quarter from -$265.2 million in Q4 2019, and down 93.07% year-on-year from -$1.8 billion in Q2 2019.

Grifols (GIKLY) Cash from Financing Activities (2010 - 2020) Analysis & Trends

Grifols (GIKLY) has reported Cash from Financing Activities for 10 consecutive years, with -$121.5 million the latest figure, recorded in Q1 2020.

  • Cash from Financing Activities for Q1 2020 came in at -$121.5 million, down 93.07% year-over-year; the trailing twelve-month figure through Mar 2020 was -$356.2 million (down 120.86% YoY), and the FY2025 annual result was -$615.8 million, up 57.6% from the prior year.
  • Cash from Financing Activities was -$121.5 million for Q1 2020 at Grifols, up from -$265.2 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $1.8 billion in Q4 2017 and troughed at -$265.2 million in Q4 2019.
  • Average Cash from Financing Activities over 5 years is $236.6 million, with a median of -$62.9 million recorded in 2019.
  • Year-over-year, Cash from Financing Activities soared 1301.8% in 2017 and sank 503.89% in 2019.
  • Over 5 years, Cash from Financing Activities stood at -$146.6 million in 2016, then soared by 1301.8% to $1.8 billion in 2017, then sank by 94.7% to $93.4 million in 2018, then sank by 383.88% to -$265.2 million in 2019, then soared by 54.2% to -$121.5 million in 2020.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$121.5 million in Q1 2020, -$265.2 million in Q4 2019, and -$62.9 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -3.47 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 530.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 919.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 267.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -2.98 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.44 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -4.24 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -2.86 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -121.48 Mn
Mar 31, 2020 -121.48 Mn
Dec 31, 2019 -265.22 Mn
Dec 31, 2019 -265.22 Mn
Mar 31, 2019 -62.92 Mn
Mar 31, 2019 -62.92 Mn
Dec 31, 2018 93.43 Mn
Dec 31, 2018 93.43 Mn
Jun 30, 2018 -207.36 Mn
Jun 30, 2018 -207.36 Mn
Mar 31, 2018 15.58 Mn
Mar 31, 2018 15.58 Mn
Dec 31, 2017 1.76 Bn
Dec 31, 2017 1.76 Bn
Jun 30, 2017 -97.45 Mn
Jun 30, 2017 -97.45 Mn
Mar 31, 2017 1.67 Bn
Mar 31, 2017 1.67 Bn
Dec 31, 2016 -146.57 Mn
Dec 31, 2016 -146.57 Mn